Congress bans recreational nitrous oxide sales, preserves medical and food uses.
H.R. 7945 — Nitrous Oxide Safety Act of 2026 · Filed by Kevin Mullin (D-CA) · 22 cosponsors · Introduced Mar 16, 2026 · Reported out
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill bans the sale of nitrous oxide consumer products (like whipped cream chargers sold for recreational inhalation) starting 180 days after enactment, treating them as hazardous products under federal consumer safety law. Medical, dental, food-service, and research uses remain legal; only recreational consumer sales are prohibited.
Why we flagged it
The bill's operative mechanism is a straightforward ban on a consumer product category deemed hazardous, with carved-out exceptions for legitimate uses. It is a public-health measure, not a market intervention or industry carve-out.
What the text implies
- Enforcement burden falls on retailers and online marketplaces; compliance cost and liability exposure may drive some smaller sellers out of the market for related products.
- The 180-day implementation window is relatively short for supply-chain adjustment; existing inventory may face disposal or liquidation pressure.
- Definition of 'consumer product' excludes food-use propellants but includes standalone chargers; the boundary may generate regulatory interpretation disputes.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
Nitrous oxide abuse carries documented public health risks including neurological damage, vitamin B12 depletion, and addiction; banning recreational consumer sales removes a readily available inhalant while preserving legitimate medical, culinary, and research uses. Citizens gain reduced exposure to a substance of abuse with minimal practical cost to lawful activities.
Named in the bill
Consumer Product Safety Commission (CPSA), Food and Drug Administration (implied regulatory authority), Retail and online commerce platforms
Where it stands
22 cosponsors: 13 Republicans, 9 Democrats.
- Mar 16, 2026 — Introduced · Congress.gov: “Introduced in House”
- Mar 16, 2026 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”
- Sep 1, 2026 — Markup held in committee · Congress.gov: “Subcommittee Consideration and Mark-up Session Held”
- Sep 16, 2026 — Reported out of committee · Congress.gov: “Ordered to be Reported by the Yeas and Nays: 36 - 0”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
1 lobbying clients named this bill on 1 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $40,000 in lobbying spend. A filing names 10 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 0% of bills with at least one filing.
Kevin Mullin, the sponsor, reported $505,911 in PAC receipts in the 2026 cycle.
- California Medical Association Inc — $40,000 on 1 filing
Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (1,866 characters) on Aug 31, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Jun 2026 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 20, 2026 · page rendered 2026-10-20.
“Congress bans recreational nitrous oxide sales, preserves medical and food uses.” QuorumCivic. https://share.quorumcivic.app/bill/119/hr7945 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.